| Active ingredients | | Date of last message | Type of reason | AM designation |
| Hydromorphone hydrochloride | Initial report | 14.11.2025 | Production problem | Palladon inject 2 mg |
| Sevelamer carbonate | Initial report | 14.11.2025 | Other | Renvela 0.8 g powder for oral suspension – OP(90×842.32mg) |
| Pirfenidone | Change notification | 14.11.2025 | Production problem | Pirfenidone Accord 801 mg film-coated tablets |
| Dinoprostone | Initial report | 14.11.2025 | Other | Minprostin E2 vaginal gel 2 mg |
| Dinoprostone | Initial report | 14.11.2025 | Other | Minprostin E2 vaginal gel 1 mg |
| Sertraline hydrochloride | Change notification | 14.11.2025 | Other | Sertraline TAD 100 mg film-coated tablets |
| Sertraline hydrochloride | Change notification | 14.11.2025 | Other | Sertraline TAD 50 mg film-coated tablets |
| Methyldopa (Ph.Eur.) | Change notification | 14.11.2025 | Other | Dopegyt tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 14.11.2025 | Other | Seroquel Prolong 150 mg prolonged-release tablets |
| Trandolapril; verapamil hydrochloride | Change notification | 13.11.2025 | Other | Tarka 240 mg/4 mg modified-release tablets |
| Posaconazole | Change notification | 13.11.2025 | Other | Posaconazole AL 40 mg/ml oral suspension |
| Methylphenidate hydrochloride | Change notification | 13.11.2025 | Other | Metiphenal 10 mg modified-release hard capsules |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 13.11.2025 | Other | Quetiapine AL 150 mg prolonged-release tablets |
| Proxymetacaine hydrochloride | Initial report | 12.11.2025 | Production problem | Proparacaine-POS 0.5% |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 12.11.2025 | Other | Seroquel Prolong 50 mg prolonged-release tablets |
| Tamsulosin hydrochloride | Initial report | 12.11.2025 | Other | Tamsulosin hydrochloride PUREN 0.4 mg prolonged-release capsules |
| Pregabalin | Change notification | 12.11.2025 | Other | Pregabalin Aurobindo 25 mg hard capsules |
| Ibuprofen | Initial report | 12.11.2025 | Production problem | Ibuprofen PUREN 600 mg film-coated tablets |
| Gabapentin | Initial report | 12.11.2025 | Other | Gabapentin Aurobindo 600 mg film-coated tablets |
| Urapidil | Initial report | 12.11.2025 | Other | Urapidil PUREN 60 mg prolonged-release capsules |
| Urapidil | Initial report | 12.11.2025 | Other | Urapidil PUREN 30 mg prolonged-release capsules |
| Fentanyl | Change notification | 12.11.2025 | Production problem | Fentanyl PUREN 25 micrograms/h transdermal patch |
| Lamotrigine | Initial report | 12.11.2025 | Production problem | Lamotrigine Aurobindo 5 mg tablets for oral suspension |
| Rizatriptan benzoate | Change notification | 12.11.2025 | Production problem | Rizatriptan PUREN 5 mg tablets |
| Sitagliptin hydrochloride monohydrate | Initial report | 12.11.2025 | Other | Sitagliptin PUREN 25 mg film-coated tablets |
| Gemcitabine hydrochloride | Initial report | 12.11.2025 | Other | Gemcitabine Aurobindo 40 mg/ml concentrate for solution for infusion |
| Mesalazine | Change notification | 12.11.2025 | Production problem | Claversal Micropellets 1.5 g |
| Risperidone | Initial report | 12.11.2025 | Other | Risperidone PUREN 3 mg film-coated tablets |
| Risperidone | Initial report | 12.11.2025 | Other | Risperidone PUREN 0.5 mg film-coated tablets |
| Mesalazine | Initial report | 12.11.2025 | Other | Claversal 500 mg tablets |
| Propranolol hydrochloride | Initial report | 12.11.2025 | Other | Propranolol PUREN 10 mg film-coated tablets |
| Buprenorphine hydrochloride | Initial report | 12.11.2025 | Other | Buprenorphine PUREN 8 mg sublingual tablets |
| Oxycodone hydrochloride (Ph.Eur.) | Initial report | 12.11.2025 | Other | Oxycodone hydrochloride Puren 10 mg prolonged-release tablets |
| Levetiracetam | Initial report | 12.11.2025 | Other | Levetiracetam PUREN 1000 mg film-coated tablets |
| Levetiracetam | Initial report | 12.11.2025 | Other | Levetiracetam Aurobindo 1000 mg film-coated tablets |
| Lamotrigine | Initial report | 12.11.2025 | Other | Lamotrigine Aurobindo 25 mg tablets |
| Efavirenz; emtricitabine; tenofovir disoproxil fumarate | Initial report | 12.11.2025 | Other | Efavirenz/emtricitabine/tenofovir disoproxil PUREN 600 mg/200 mg/245 mg film-coated tablets |
| Linezolid | Initial report | 12.11.2025 | Other | Linezolid PUREN 600 mg film-coated tablets |
| Risperidone | Initial report | 12.11.2025 | Other | Risperidone Aurobindo 1 mg film-coated tablets |
| Olanzapine embonate monohydrate | Initial report | 11.11.2025 | Production problem | ZYPADHERA 405 mg powder and solvent for the preparation of a depot injection suspension – OP(931mg+3ml) |
| Aprepitant | Change notification | 11.11.2025 | Other | Aprepitant AL 125 mg hard capsules |
| Oxazepam | Change notification | 11.11.2025 | Other | Oxazepam AL 10 |
| Ciprofloxacin hydrochloride (1:1) 1 H<2>O | Change notification | 11.11.2025 | Other | Ciprohexal 100 mg |
| Ciprofloxacin hydrochloride (1:1) 1 H<2>O | Change notification | 11.11.2025 | Other | Cipro-1 A Pharma 100mg |
| Terbutaline sulfate (Ph.Eur.) | Change notification | 11.11.2025 | Production problem | BRICANYL 0.5 mg |
| Nimodipine | Change notification | 10.11.2025 | Other | Nimodipine Hexal 30mg |
| Insulin lispro | Initial report | 10.11.2025 | Other | Liprolog 100 E/ml solution for injection in cartridge – OP[2x(5x3ml)] |
| Human insulin (with manufacturing details) | Initial report | 10.11.2025 | Other | Huminsulin Normal KwikPen 100 IU/ml solution for injection |
| Calcium trisodium pentetate (with information on water content, if applicable) | Initial report | 10.11.2025 | Other | Technescan DTPA |
| Sevelamer | Change notification | 10.11.2025 | Other | Renagel 800 mg film-coated tablets – OP(1×180) |
| Tenofovir disoproxil fumarate | Initial report | 10.11.2025 | Other | Tenofovir disoproxil PUREN 245 mg film-coated tablets |
| Lidocaine | Initial report | 10.11.2025 | Other | XYLOCAIN PUMP SPRAY |
| Vinflunine bis[(R,R)-tartrate] | Initial report | 10.11.2025 | Production problem | Javlor 25 mg/ml concentrate for solution for infusion – OP (1x2ml) |
| Ipratropium bromide (Ph.Eur.); salbutamol sulfate | Change notification | 10.11.2025 | Production problem | Ipratropium/salbutamol Cipla 0.5 mg/2.5 mg solution for nebulizer |
| Valsartan | Initial report | 10.11.2025 | Production problem | Valsartan STADA 80 mg film-coated tablets |
| Valsartan | Initial report | 10.11.2025 | Production problem | Valsartan STADA 160 mg film-coated tablets |
| Aprepitant | Initial report | 10.11.2025 | Other | EMEND 125 mg powder for oral suspension – OPXXXXmg |
| Amikacin sulfate | Change notification | 10.11.2025 | Production problem | Amikacin B. Braun 2.5 mg/ml solution for infusion |
| Amikacin sulfate | Change notification | 10.11.2025 | Production problem | Amikacin B. Braun 5 mg/ml solution for infusion |
| Tolterodine tartrate | Change notification | 10.11.2025 | Other | Detrusitol 2 mg film-coated tablets |
| Ipratropium bromide | Change notification | 10.11.2025 | Production problem | Ipratropium bromide 125 micrograms/1 ml Stulln |
| Duloxetine hydrochloride | Initial report | 10.11.2025 | Other | Cymbalta 60 mg gastro-resistant hard capsules – OP28 |